Biologic Determinants of Tumor Recurrence in Stage II Colon Cancer: Validation Study of the 12-Gene Recurrence Score in Cancer and Leukemia Group B (CALGB) 9581

MLA

C. Millward, et al. “Biologic Determinants of Tumor Recurrence in Stage II Colon Cancer: Validation Study of the 12-Gene Recurrence Score in Cancer and Leukemia Group B (CALGB) 9581.” Journal of Clinical Oncology, vol. 31, May 2013, pp. 1775–81. EBSCOhost, https://doi.org/10.1200/jco.2012.45.1096.

APA

C. Millward, Donna Niedzwiecki, Xing Ye, Kim M. Clark-Langone, Mark Lee, Margarita Lopatin, Paula N. Friedman, Alan P. Venook, Robert S. Warren, Monica M. Bertagnolli, Richard L. Schilsky, Steven Shak, Wendy L. Frankel, Najjia N. Mahmoud, & Richard M. Goldberg. (2013). Biologic Determinants of Tumor Recurrence in Stage II Colon Cancer: Validation Study of the 12-Gene Recurrence Score in Cancer and Leukemia Group B (CALGB) 9581. Journal of Clinical Oncology, 31, 1775–1781. https://doi.org/10.1200/jco.2012.45.1096

Chicago

C. Millward, Donna Niedzwiecki, Xing Ye, Kim M. Clark-Langone, Mark Lee, Margarita Lopatin, Paula N. Friedman, et al. 2013. “Biologic Determinants of Tumor Recurrence in Stage II Colon Cancer: Validation Study of the 12-Gene Recurrence Score in Cancer and Leukemia Group B (CALGB) 9581.” Journal of Clinical Oncology 31 (May): 1775–81. doi:10.1200/jco.2012.45.1096.